Go Pro

Core Laboratories (CLB) Stock Price, News & Analysis

Core Laboratories logo
$10.65 +0.30 (+2.88%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$10.65 +0.00 (+0.02%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Core Laboratories Stock (NYSE:CLB)

Advanced

Key Stats

Today's Range
$10.22
$10.90
50-Day Range
$9.87
$14.52
52-Week Range
$9.72
$20.36
Volume
774,822 shs
Average Volume
804,549 shs
Market Capitalization
$490.87 million
P/E Ratio
19.01
Dividend Yield
0.38%
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement. In reservoir description, Core Laboratories performs detailed analyses on drill-cuttings, cores and reservoir fluids to characterize rock and fluid properties. Under production enhancement, the company offers well stimulation, downhole chemistry, and scale and corrosion management solutions designed to improve flow rates and mitigate operational risks. These services are supported by a global network of research laboratories and field service centers equipped with advanced instrumentation.

Headquartered in Amsterdam with key operating offices in Houston, Core Laboratories conducts business in more than 50 countries across six continents, serving major international and national oil companies, as well as independents. The company’s engineering and technical teams collaborate closely with clients to tailor solutions to diverse reservoir environments. Under the leadership of President and CEO Clay C. Williams, Core Laboratories continues to invest in innovation and technology development to address evolving challenges in reservoir management and production optimization.

AI Generated. May Contain Errors.

Core Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

CLB MarketRank™: 

Core Laboratories scored higher than 52% of companies evaluated by MarketBeat, and ranked 156th out of 246 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Core Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Core Laboratories has only been the subject of 1 research reports in the past 90 days.

  • Read more about Core Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Core Laboratories are expected to grow by 49.06% in the coming year, from $0.53 to $0.79 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Core Laboratories is 19.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 46.01.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Core Laboratories is 19.01, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 19.40.

  • Price to Earnings Growth Ratio

    Core Laboratories has a PEG Ratio of 2.57. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Core Laboratories has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    8.84% of the float of Core Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Core Laboratories has a short interest ratio ("days to cover") of 2.49, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Core Laboratories has recently decreased by 32.62%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Core Laboratories has a dividend yield of 0.38%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Core Laboratories does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Core Laboratories is 7.14%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

  • Read more about Core Laboratories' dividend.
  • News Sentiment

    Core Laboratories has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Energy companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Core Laboratories this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Core Laboratories insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.26% of the stock of Core Laboratories is held by insiders.

  • Percentage Held by Institutions

    97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Core Laboratories' insider trading history.
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLB Stock News Headlines

Core Laboratories (NYSE:CLB) Upgraded at Wall Street Zen
Core Laboratories (CLB) Q2 2026 Earnings
They’re still buying the wrong AI stocks
Tesla and Alphabet just tumbled, and many investors concluded AI is over. It isn't - the easy AI trade may be. History shows a similar pattern: Cisco collapsed in 2000, but the internet went on to reshape the world. The lesson applies now as markets question massive AI infrastructure spending. The real opportunity may be Phase 2 AI stocks - companies using AI to dominate cybersecurity, logistics, pharma, and other essential industries.tc pixel
Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript
CORE LAB REPORTS SECOND QUARTER 2026 RESULTS
See More Headlines

CLB Stock Analysis - Frequently Asked Questions

Core Laboratories' stock was trading at $16.02 on January 1st, 2026. Since then, CLB shares have decreased by 33.5% and is now trading at $10.6480.

Core Laboratories Inc. (NYSE:CLB) released its earnings results on Wednesday, July, 29th. The oil and gas company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.09 by $0.02. Core Laboratories's quarterly revenue was down 4.3% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional shareholders of Core Laboratories include GAMMA Investing LLC (0.01%).
View institutional ownership trends
.

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Record date for 6/1 Dividend
5/11/2026
Ex-Dividend for 6/1 Dividend
5/11/2026
Dividend Payable
6/01/2026
Last Earnings
7/29/2026
Today
8/02/2026
Record date for 8/31 Dividend
8/10/2026
Ex-Dividend for 8/31 Dividend
8/10/2026
Dividend Payable
8/31/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Energy
Industry
Energy Equipment & Services
Sub-Industry
Oil & Gas Equipment & Services
Current Symbol
NYSE:CLB
CIK
1958086
Fax
N/A
Employees
3,300
Year Founded
1936

Profitability

EPS (Trailing Twelve Months)
$0.56
Trailing P/E Ratio
19.01
Forward P/E Ratio
20.09
P/E Growth
2.57
Net Income
$29.67 million
Net Margins
5.10%
Pretax Margin
7.09%
Return on Equity
10.03%
Return on Assets
4.71%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
2.12
Quick Ratio
1.50

Sales & Book Value

Annual Sales
$526.52 million
Price / Sales
0.93
Cash Flow
$1.07 per share
Price / Cash Flow
9.96
Book Value
$6.05 per share
Price / Book
1.76

Miscellaneous

Outstanding Shares
46,100,000
Free Float
45,516,000
Market Cap
$490.87 million
Optionable
Optionable
Beta
1.00

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NYSE:CLB) was last updated on 8/2/2026 by MarketBeat.com Staff.
From Our Partners